Retirement Guys Formula LLC Buys 389 Shares of The Clorox Company (NYSE:CLX)

Retirement Guys Formula LLC grew its stake in The Clorox Company (NYSE:CLX) by 7.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,450 shares of the company’s stock after acquiring an additional 389 shares during the quarter. Retirement Guys Formula LLC’s holdings in Clorox were worth $885,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Catalyst Capital Advisors LLC bought a new stake in shares of Clorox in the 3rd quarter valued at about $54,000. Los Angeles Capital Management LLC increased its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. increased its stake in shares of Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after acquiring an additional 9,037 shares during the last quarter. Natixis Advisors LLC grew its position in shares of Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 0.9 %

NYSE CLX opened at $148.47 on Wednesday. The company has a market cap of $18.38 billion, a PE ratio of 40.56, a PEG ratio of 2.52 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a 50 day moving average of $160.68 and a 200-day moving average of $159.16.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm posted $2.16 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CLX shares. Evercore ISI boosted their price objective on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Wells Fargo & Company boosted their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Clorox currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.